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The experiments by Sultzer and Nilsson (1), and later by Watson and Riblet 
(2),  established  that  spleen  cells  from the  C3H/HeJ  strain  of mouse  were 
refractory to the mitogenic effects of bacterial lipopolysaccharides (LPS).  More 
recently,  however,  experiments from  our  laboratory  (3)  demonstrated that 
spleen cells from C3H/HeJ mice were in fact responsive to some preparations of 
LPS but not to others, and that the method of extraction played a critical role in 
determining activity. In particular, preparations of LPS prepared by extraction 
with aqueous butanol had potent mitogenic activity. Our data showed that the 
mitogenic activity of such positive preparations of LPS coisolated with the LPS 
during gel filtration chromatography and subsequent equilibrium banding on 
CsC1. In addition, lipid A isolated from positive preparations of LPS was also 
capable of stimulating C3H/HeJ spleen cells. Taken together, these experiments 
provided rather convincing data that it was the LPS (in particular the lipid A) 
itself,  or  some  contaminant very tightly bound  to  the  lipid  A,  which  was 
responsible for its biological  activity. 
We further demonstrated that treatment of positive preparations of LPS with 
hot phenol rendered such preparations nonmitogenic for C3H/HeJ spleens, yet 
activity for other strains was only moderately decreased. These experiments 
would suggest either that the phenol treatment chemically alters the lipid A 
region of the LPS molecule or that such treatment removes the putative tightly 
bound contaminant responsible for C3H/HeJ mitogenesis. 
In the experiments reported here, we have explored in greater detail the role 
of lipid A in the stimulation of C3H/HeJ spleen cells. For these experiments we 
have utilized our earlier observations that the antibiotic polymyxin B forms a 
highly stable molecular complex with the lipid A region of LPS (4), and that 
such  polymyxin B-LPS  complexes are  unable  to  mitogenically stimulate  B 
lymphocytes (5). In addition, we have attempted to distinguish between the two 
potential modes of action of phenol on LPS, namely, the chemical alteration of 
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the lipid A or the removal of a tightly bound contaminant by phenol treatment. 
The results of the experiments we report here support the interpretation  that 
mitogenic activity of positive preparations of LPS is associated with a  low mol 
wt phenol  soluble polypeptide of approximately  10,000  mol  wt.  After partial 
purification,  this polypeptide initiates a  significant mitogenic response at con- 
centrations as low as 10 ~tg/ml. We conclude that the C3H/HeJ strain of mouse is 
a true nonresponder to the stimulatory effects of the lipid A region of LPS. 
Materials  and Methods 
The LPS from Escherichia coli 0111:B4 was extracted either with butanol (B-LPS) (6) or with 
phenol (7) purified and fractionated into high lipid A  (LPS-II) and low lipid A (LPS-I) (percent by 
weight) as previously described (6). All of the experiments reported here have utilized the LPS II 
fraction. The conditions used for inhibition of mitogenesis by polymyxin B were as described by 
Jacobs and Morrison (5). CBA/WEHI mice were bred at the Salk Institute, La Jolla, Calif.; C3H/ 
HeJ mice were obtained from The Jackson Laboratory, Bar Harbor, Maine; and C3H/St mice were 
obtained  from  Strong  Laboratories,  Sorrento  Valley,  Calif.  Spleen  cells  were  cultured  at  a 
concentration of 2.5 ×  l0  s viable cetls/ml in 200 ~l of RPMI 1640 supplemented with glutamine, 5% 
fetal calf serum, 100 U/ml penicillin, and 100/~g/ml streptomycin in an atmosphere of 95% air, 5% 
CO2.  After 1 or 2 days of culture, 0.5/~Ci of [SH]thymidine (10.6 Ci/mM, New England Nuclear, 
Boston, Mass.) or 0.05/~Ci 1~sI-UdR (sp act >200 Ci/mM, New England Nuclear, Boston, Mass.) 
were added and the cells incubated an additional 24 h. Cells were then harvested using a multiple 
automated sample harvester (Microbiological Associates, Bethesda, Md.) and assayed for incorpo- 
rated radioactivity. All data represent the average of duplicate or triplicate samples. LPS concen- 
trations were estimated by the assay for dideoxyhexoses using thiobarbituric acid (8), and protein 
was estimated by the Folin phenol procedure (9). 
Results 
Our initial experiments attempted to define further the participation of lipid 
A in the mitogenic response of both responder (CBA/WEHI) and nonresponder 
(C3H/HeJ) spleen cells to both positive (B-LPS) and negative (P-LPS) prepara- 
tions  of LPS.  To  do this,  spleen  cells  were cultured  in  the  presence  of both 
preparations  of LPS  in  the  presence  and  absence  of the  lipid  A  inhibitor, 
polymyxin B. The T-cell mitogens concanavalin A (Con A) and phytohemagglu- 
tinin  (PHA) and another B-cell mitogen purified protein derivative (PPD) were 
used to control for nonspecific effects of polymyxin B. The results of one such 
experiment are shown in Table I and demonstrate several salient points. First, 
as we have shown previously (3),  B-LPS has the capacity to stimulate spleen 
cells from both strains of mice,but P-LPS can stimulate only the responder cells. 
Second, the P-LPS response, as would be predicted (5), is completely abrogated 
in the presence of polymyxin B. Third,  polymyxin B  has  very little  effect on 
other B- or T-cell mitogens, including Con A, PHA, and PPD, insuring that the 
polymyxin B effect is not nonspecific. Finally, however, and perhaps somewhat 
surprisingly, polymyxin B has, in addition, virtually no effect on the mitogenic 
response of spleen cells to B-LPS.  Extraction  of B-LPS with phenol  (data not 
shown) gave results identical to those obtained with P-LPS. These data,  there- 
fore, indicate either that it is not the lipid A in B-LPS which is responsible for 
the mitogenic activity or that polymyxin B, for some reason, does not interact 
with the lipid A of B-LPS. 
To  examine  this  latter  possibility  in  greater  detail,  we  have  utilized  our 
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TABLE  I 
Effect of Polymyxin B on the Incorporation  of ~2sI-UdR into Murine 
Spleen Cells Stimulated by Various Mitogens* 
CBA/WEHI  C3H/HeJ 
-PB  +PB*  -PB  +PB 
cpm  ×  10  ~ 
Con A  (0.25  ,u.g)  199.9  180.6  142.9  149.7 
PHA  (0.12  ,~g)  170.0  145.1  153.0  126.8 
P.LPS  (I,0  ~g)  53,7  1.7  3.5  1.6 
B-LPS  (1.0 t~g)  169.8  138.8  20.9  23.7 
PPD  (20 ~g)  27.1  30,8  8.4  8.5 
Control  1.2  1.7  1.3  2,3 
* 5,9 × I0  ~  spleen cells  in 200 pl of  media were cultured for  48 h in  the presence of  the indicated amounts 
of the various mitogens,  after which 0.05  ~Ci of '2sI-UdR was added and the cells incubated an 
additional 24 h. 
* l,O ~g of  polymyxin B  (PB) was added to the cultures. 
molecular weights and may be distinguished from untreated LPS by gel filtra- 
tion chromatography on Sepharose 4B (4). An equal weight of polymyxin B was 
incubated with either B-LPS or P-LPS for 30 min at 37°C,  after which the LPS 
was chromatographed.  Control LPS was incubated in the absence of polymyxin 
B. As shown in Fig. 1, addition of polymyxin B to P-LPS caused the characteris- 
tic  shift  to  higher  apparent  molecular  weight  (4).  In  contrast,  addition  of 
polymyxin B to B-LPS had no detectable effect on this LPS, whose chromato- 
graphic profile was identical to control B-LPS. (Again, treatment of B-LPS with 
phenol  gave  results  identical  to  those  obtained  with  P-LPS.)  These  data,  in 
addition to the mitogen data described above, suggest that the lipid A of B-LPS 
is blocked in its ability to interact with polymyxin B. 
A  consideration of several pertinent observations may provide further infor- 
mation on the nature  of the interaction  of polymyxin B  to interact  with LPS 
prepared  by different extraction  procedures.  First,  we have  shown that  poly- 
myxin  B  binds  to  the  lipid  A  region  of phenol-extracted  LPS  and  causes  a 
decrease in the isopycnic density of such complexes (4).  Second, polymyxin B 
does not bind to butanol-extracted LPS (Fig. 1). Third, re-extraction of butanol- 
extracted LPS with phenol causes an increase in isopycnic density (6) approxi- 
mately equal to the shift in density seen upon addition of polymyxin B to phenol 
LPS.  These  observations  are  consistent  with  an  interpretation  of a  distinct 
biologically active moiety associated with the lipid A of B-LPS. This biologically 
active moiety may bind to the same region of the lipid A as polymyxin B would, 
be responsible for C3H/HeJ mitogenesis, and be removed by treatment with hot 
aqueous phenol. 
As the mitogenic activity for C3H/HeJ spleen cells is abrogated by treatment 
with phenol,  the putative polypeptide bound to the lipid A  of B-LPS is either 
chemically  destroyed  or  is  insoluble  in  aqueous  solvents.  In  an  attempt  to 
distinguish between these two possibilities, we have extracted purified B-LPS II 
with phenol as described by Westphal and Jann  (7). However, in these experi- 
ments we have focused upon the phenol phase. Approximately 30 mg of B-LPS II 
in 6 ml of H20 were extracted with an equal vol of 90% phenol for 15 min at 68 +_ 
lec. After cooling and centrifugation,  the aqueous phase was removed, and the 
resultant phenol phase and interface re-extracted two times as described above. MORRISON  ET  AL.  BRIEF  DEFINITIVE  REPORT  843 
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FIa.  1.  Effect of polymyxin B on the chromatographic properties of preparations of LPS. 
Approximately 500 ~g of LPS prepared by either butanol or phenol extraction were incu- 
bated with or without an equal weight of polymyxin B in a final vol of 500 ~l of saline as 
described  in the text.  The LPS was then chromatographed  on a  1.5  x  32  cm column of 
Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N. J.) equilibrated with 0.1 M Tris, 
pH 8.0.  Portions of volume fractions were assayed for the presence of LPS by the thiobarbi- 
turic acid assay for dideoxyhexoses (8). 
The phenol phase was then carefully concentrated by flash evaporation at 30°C 
under reduced pressure and finally lyophylized. A yield of approximately 5 mg of 
material resulted. The material contained no detectable LPS, as measured by 
the dideoxyhexose assay for colitose (8), and, as estimated by the Folin phenol 
procedure (9), the extracted residue was greater than 95% protein. 
When examined for its ability to stimulate spleen cells from both responder 
and  nonresponder mice,  this  material  was  shown  to  have  potent  mitogenic 
properties  with  as  little  as  0.2  ~g  initiating  a  significant  increase  in 
[3H]thymidine incorporation over background in both strains.  Representative 
data from one such experiment is shown in Table II. It is interesting to note that 
the phenol extract appears to have a similar specific activity as does the butanol 
LPS.  Whether  this  represents  some  deleterious effect of the  phenol  on  the 
subsequent biological activity of the extract is not, at present, clear. We have, in 
addition,  demonstrated that,  as  predicted,  the  phenol-soluble  extract  is  not 
inhibited by polymyxin B. 844  MORRISON  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Mitogenic Response of Spleen Cells to Phenol-Soluble Extract of 
Butanol-Purified  LPS* 
C3H/St  C3H/HeJ 
cpm  ×  10  :~ 
P-LPS  20  ~,g  16.1  1.5 
2  ~g  10.4  1.2 
0.2 p,g  8.8  1.3 
B-LPS  20  ~g  43.9  22.1 
2  ~g  20.7  11.5 
0.2 ~zg  12,7  3.0 
Phenol-soluble extract  20  ~g  38.5  23.6 
2  ~g  19.1  12.4 
0,2 gg  11.0  3.6 
Control  4.1  1.1 
* Spleen cells were cultured as described in the legend to Table I except that cells were pulsed 
with 0.50 ~Ci of [3H]thymidine after 24 h  of incubation and harvested after 24 h to maximize 
the C3H/HeJ response  (reference 3}, 
TABLE  III 
Mitogenic Activity of Sephadex  G-75 Purified Low Molecular 
Weight Polypeptide from B-LPS* 
C3H/St  C3H/HeJ 
cpm  ×  10  " 
P-LPS  2  ~g  28.6  7.4 
0.2 ~g  14.7  5.0 
B-LPS  2  ~g  69.8  23.5 
0.2 ~g  27.8  5.5 
Polypeptide  2  ~g  17.4  12.7 
0.2 ~g  9.4  5.6 
Control  4.5  2.1 
* Spleen cells were treated as described in the legend to Table II. 
The extract was then solubilized in 10% formic acid and subjected to chroma- 
tography on Sephadex G-75 superfine. An analysis of the protein elution profile 
demonstrated that most of the protein eluted as a  single peak slightly preced- 
ing  the  column  inclusion  volume  at  a  mol  wt  of about  10,000.  The  column 
fractions containing this major peak were pooled, lyophylized, resuspended in a 
small volume of saline,  and assayed for capacity to stimulate spleen cells.  As 
shown  in  Table  III,  this  low  molecular  weight  polypeptide  itself initiated  a 
significant  response  above  background  in  both  responder  and  nonresponder 
spleen cells. 
Discussion 
Our data thus provide evidence that the mitogenic activity of positive prepa- 
rations of LPS for spleen cells from the C3H/HeJ mouse is associated with a low 
molecular weight polypeptide which on the basis of our earlier observations (3) 
appears to be associated with the lipid A region of the LPS. Proteins associated 
with LPS have earlier been described by Leive et al.  (10) after treatment of E. MORRISON  ET AL.  BRIEF DEFINITIVE  REPORT  845 
coli 0111:B4 with the divalent chelator ethylenediaminetetraacetic acid. More 
recently, Wu and Heath (11) have demonstrated a low molecular weight protein 
associated with the LPS ofE. coli 0111:B4 after extraction of the bacteria with 
sodium dodecyl sulfate. Their report of an approximate mol wt of about 12,000 is 
in agreement with our data reported here. Finally, Sultzer and Goodman (12) 
have  elsewhere  in  this  issue  described  a  protein  associated with  LPS  after 
extraction by mild procedures, such as trichloroacetic acid, which is both mito- 
genic and a polyclonal activator of C3H/HeJ spleen cells. It is probable that all of 
these proteins represent the same LPS-bound polypeptide. 
Braun and co-workers (13, 14) have isolated and characterized a low molecular 
weight lipoprotein which is associated with the murein layer of the cell wall of 
gram negative bacteria. More recently, Melchers et al. (15) have demonstrated 
that this lipoprotein is a potent mitogen for lymphocytes from C3H/HeJ as well 
as other strains. The relationship between this lipoprotein and the one we and 
Wu and Heath (11) and Sultzer and Goodman (12) describe here at present is 
unclear. The fact that their protein is associated with the murein layer, whereas 
ours appears tightly bound to LPS, the lipid A region of the LPS, might suggest 
that they are not identical. 
What emerges from these and other studies is the rather exciting observation 
that many of  the potent B-cell mitogens now isolated and partially characterized 
have as their origin the bacterial cell wall, including PPD (1), peptidoglycans 
(16), lipid A  (17), the murein-binding lipoprotein (15), and the lipid A-binding 
polypeptide described here. A consideration of the physical-chemical properties 
of these various mitogens should provide further insight into the mechanisms of 
the initiation of B-cell mitogenesis. In any case, it seems relatively certain that 
the  initial description of Sultzer  (1)  of the  C3H/HeJ mouse as being a  true 
nonresponder to the mitogenic effects of LPS (lipid A) was indeed an accurate 
one. 
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